Business Wire

Vifor Pharma Group Announces Successful Sale of OM Pharma

Share

Regulatory News:

Vifor Pharma has today announced the successful sale of 100% of the share capital of OM Pharma, a Vifor Pharma Group company to Optimus Holding Ltd. The terms of the deal include:

  • A purchase consideration of MCHF 435 for 100% of the share capital
  • An earn out related to potential future value gains on 20% of Optimus Holding Ltd. equity to be determined before the end of 2027 upon a trade sale, IPO or EBITDA multiple

This earn out together with the purchase consideration could result in a total transaction value exceeding MCHF 500. The deal is expected to close within 30 days.

OM Pharma is a Geneva-based company mainly active in the field of microbial derived immunotherapeutics and has developed strongly outside the core strategy of Vifor Pharma over the past few years.

Optimus Holding Ltd. is a Swiss Group, founded by Etienne Jornod together with long-standing Swiss entrepreneurs and Abdi Ibrahim (28.5%), a Turkey-based pharmaceutical company operating in 12 countries and exporting to 60 countries worldwide, as a strategic partner. Optimus Holding is fully committed to the sustainable growth of OM Pharma and to invest considerably in R&D to become a global biotechnology company focused on improving the lives of patients with respiratory and inflammatory diseases.

Stefan Schulze, CEO of Vifor Pharma Group comments, “I am very pleased to have successfully completed the competitive sale process of OM Pharma announced earlier this year that was overseen by Rothschild & Co. Optimus Holding Ltd. brings a wealth of expertise and OM Pharma will benefit from the knowledge, financial investment and operational synergies of the new owners. This sale strengthens our strategic focus and will enable the company to further invest into our exciting product pipeline, especially in our core therapeutic area of nephrology.”

Vifor Pharma Group is a global pharmaceuticals company. It aims to become the global leader in iron deficiency, nephrology and cardio-renal therapies. The company is the partner of choice for pharmaceuticals and innovative patient-focused solutions. Vifor Pharma Group strives to help patients around the world with severe and chronic diseases lead better, healthier lives. The company develops, manufactures and markets pharmaceutical products for precision patient care. Vifor Pharma Group holds a leading position in all its core business activities and consists of the following companies: Vifor Pharma; Vifor Fresenius Medical Care Renal Pharma (a joint company with Fresenius Medical Care); and OM Pharma. Vifor Pharma Group is headquartered in Switzerland, and listed on the Swiss Stock Exchange (SIX Swiss Exchange, VIFN, ISIN: CH0364749348). For more information, please visit viforpharma.com.

Contact information

Vifor Pharma Group:
Media Relations
Nathalie Ponnier
Global Head of Corporate Communications
+41 79 957 96 73
media@viforpharma.com

Investor Relations
Julien Vignot
Head of Investor Relations
+41 58 851 66 90
investors@viforpharma.com

Optimus Holding Ltd.:
Beatrix Benz
+41 79 256 77 73
beatrix.benz@benz-advisory.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Axway creates return-to-work app. Releases source code to the public.27.10.2020 18:00:00 EETPress release

Axway (Euronext: AXW.PA), a leading provider of API Management and integration software, announces the release of the source code for Axway’s mobile office scheduling assistant, the Griffin App. Their goal is to help other companies return to the office safely using APIs and mobile technology. To return to the office in each of the 17 countries Axway employees work, its teams had to follow varying requirements for opening, depending on the region. These include government regulations, building regulations, and localized screening questions unique for each location. Thanks to the Griffin App, employees can now see the current and scheduled capacity for any specific office on a given date, then prepare their workday accordingly. “With over two thousand employees in nearly 30 offices, we were looking for the best solution to empower employees in their choice to utilize our office spaces throughout the world,” said Dominique Fougerat, EVP People & Culture at Axway. “The Griffin App helps A

Calabrio Unveils New Platform for a New Era of Workforce and Customer Engagement27.10.2020 17:00:00 EETPress release

Calabrio, the customer experience intelligence company, today unveils the new Calabrio ONE workforce engagement management (WEM) suite at its first-ever virtual Calabrio Customer Connect (C3) conference, October 27-28, 2020. The new Calabrio ONE is a cloud-based WEM platform designed to meet the performance, agility and engagement demands of the modern contact center in the new era of work and customer experience. The pandemic has shifted the world of work and elevated the importance of agility in the contact center via employee empowerment tools, intelligent workflows and automation, and visibility into agent-customer interactions through data-driven insights. With last year’s acquisition of Teleopti, Calabrio pledged to bring the two leading workforce management (WFM) offerings together under one unified WFM product. Calabrio delivers on this promise with the new Calabrio WFM – with the best of both products at its core – resulting in a fully integrated WEM suite poised to help custo

IDEMIA Will Present Its Q3 2020 Financial Results to Investors on November 2, 202027.10.2020 17:00:00 EETPress release

IDEMIA, the world leader in Augmented Identity, today announced that it will present its Q3 2020 financial results to investors on Monday November 2, 2020. Pierre Barrial (President & CEO) and Laurent Lemaire (CFO) will be presenting the financial results and taking questions the same day at 4:00 pm CET (3:00 pm London Time / 10:00 am New York Time). For more information, please refer to our website: https://investors.idemia.com/ About IDEMIA IDEMIA, the global leader in Augmented Identity, provides a trusted environment enabling citizens and consumers alike to perform their daily critical activities (such as pay, connect and travel), in the physical as well as digital space. Securing our identity has become mission critical in the world we live in today. By standing for Augmented Identity, an identity that ensures privacy and trust and guarantees secure, authenticated and verifiable transactions, we reinvent the way we think, produce, use and protect one of our greatest assets – our i

INX to Acquire Openfinance Securities, LLC27.10.2020 16:54:00 EETPress release

INX Limited (“ INX ”), the global blockchain-based platform for trading digital assets, announced today it has signed a term-sheet for the acquisition of Openfinance Securities LLC, a registered U.S. broker-dealer operating a registered FINRA/SIPC member, with an alternative trading system (ATS) (“Openfinance”). Subject to the execution of definitive agreements, regulatory approvals, and other closing conditions, INX would acquire Openfinance’s broker-dealer and ATS business including its systems, digital asset listings, client base and licenses. Openfinance is based in Chicago with offices in New York and Pennsylvania. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201027005773/en/ Shy Datika, Co-Founder and President, INX (Photo: Business Wire) INX aims to bolster its leadership position in the digital assets’ ecosystem with the acquisition of Openfinance, one of the pioneers of regulated trading platforms in this space. O

Nexeo Plastics Signs EMEA Distribution Agreement with KuibyshevAzot Affiliate27.10.2020 16:54:00 EETPress release

Nexeo Plastics, a leading global thermoplastics resin distributor, has signed an agreement with STFG Filamente GmbH, an affiliate of KuibyshevAzot, a Russian-based chemicals company, to distribute their polyamide 6-based (PA6) products throughout Europe. “We are excited to join with Nexeo Plastics and become part of their extensive distribution network, providing our customers more choices and outstanding customer service across Europe,” said Dmitriy Rybkin, director of marketing. “The Volgamid™ line of resins offer end users a variety of choices, including sustainable recycling materials for high-end applications.” Nexeo Plastics will carry and distribute the Volgamid™ ECO-line series. ECO-line materials are environmentally friendly solutions that help reduce CO2 emissions and offer end users a circular economy manufacturing option. With two choices — the ECO-G6A line, a mostly prime/recycled material mix and the ECO-G6B line with 100% recycled materials — manufacturers can specifical

Andersen Global Adds Additional Presence in Jamaica27.10.2020 16:30:00 EETPress release

Further strengthening its foothold in the Jamaican market and in the Caribbean region, Andersen Global adds collaborating firm Myers, Fletcher & Gordon, the largest law firm in the country. Founded in 1944, Myers, Fletcher & Gordon provides legal services to global corporations, government agencies and individuals with local and international expertise in various industries such as tourism, transportation, financial services, telecommunications, mining, energy and labor. Its full-service capabilities include litigation, corporate and commercial law, real estate law, intellectual property, tax law, property law, sports law, competition, aviation, and financial regulation and trade. “Our ability to deliver best-in-class solutions is enhanced by our extensive resources and broad expertise, and this collaboration further equips our growing capabilities,” Managing Partner Peter Goldson said. “Our client-focused approach and commitment to stewardship deeply aligns with Andersen Global’s cult

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom